Indian Transforming Alzheimer's Care Training (INTACT) - Trial NCT06397339
Access comprehensive clinical trial information for NCT06397339 through Pure Global AI's free database. This phase not specified trial is sponsored by Washington State University and is currently Recruiting. The study focuses on Alzheimer Disease. Target enrollment is 28 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Washington State University
Timeline & Enrollment
N/A
Oct 05, 2022
Apr 30, 2026
Primary Outcome
Clinic Level - new diagnoses of ADRD and MCI (Aim 2),PCP level - care confidence (Aim 1),Patient level - quality of care 1 (Aim 3),Patient level - quality of care 2 (Aim 3),Patient level - quality of care 3 (Aim 3),Patient level - quality of care 4 (Aim 3),Patient level - quality of care 5 (Aim 3),Patient level - quality of care 5 (Aim 3)
Summary
INTACT will utilize a group-randomized trial, to test the effectiveness of a culturally
 informed provider training and dementia friendly clinic intervention for detection and
 appropriate management of AI/AN patients with ADRD and MCI in 28 urban and rural clinics
 serving AI/ANs.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06397339
Non-Device Trial